Literature DB >> 15536559

Transvenous injection of Onyx for casting of the cavernous sinus for the treatment of a carotid-cavernous fistula.

Anil Arat1, Saruhan Cekirge, Isil Saatci, Burce Ozgen.   

Abstract

A complex case of carotid-cavernous fistula was treated transvenously by injection of ethyl vinyl alcohol co-polymer into the cavernous sinus after an unsuccessful embolization attempt with detachable coils and liquid adhesive agents. There were no complications. At 3 months the patient's symptoms had resolved completely, and a control angiogram revealed persistent occlusion. The physical properties of ethyl vinyl alcohol polymer justify further investigation of this agent for the treatment of carotid-cavernous fistula.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15536559     DOI： 10.1007/s00234-004-1244-9

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


  10 in total

Review 1.  Carotid artery cavernous fistulas.

Authors:  C C Phatouros; P M Meyers; C F Dowd; V V Halbach; A M Malek; R T Higashida
Journal:  Neurosurg Clin N Am       Date:  2000-01       Impact factor: 2.509

2.  Endovascular treatment of giant and large intracranial aneurysms by using a combination of stent placement and liquid polymer injection.

Authors:  Michel E Mawad; Saruhan Cekirge; Elisa Ciceri; Isil Saatci
Journal:  J Neurosurg       Date:  2002-03       Impact factor: 5.115

3.  Treatment of bilateral spontaneous dural carotid-cavernous fistulas by coils and sclerotherapy. Case report.

Authors:  P Courtheoux; D Labbe; C Hamel; P J Lecoq; M Jahara; J Théron
Journal:  J Neurosurg       Date:  1987-03       Impact factor: 5.115

4.  Embolization of dural cavernous fistulas via superior ophthalmic vein approach.

Authors:  D Quiñones; G Duckwiler; P Y Gobin; R A Goldberg; F Viñuela
Journal:  AJNR Am J Neuroradiol       Date:  1997-05       Impact factor: 3.825

5.  Transarterial embolisation of complex cavernous sinus dural arteriovenous fistulae with low-concentration cyanoacrylate.

Authors:  H M Liu; Y C Huang; Y H Wang; Y K Tu
Journal:  Neuroradiology       Date:  2000-10       Impact factor: 2.804

6.  Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients.

Authors:  R Jahan; Y Murayama; Y P Gobin; G R Duckwiler; H V Vinters; F Viñuela
Journal:  Neurosurgery       Date:  2001-05       Impact factor: 4.654

7.  Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile.

Authors:  Y Murayama; F Viñuela; A Ulhoa; Y Akiba; G R Duckwiler; Y P Gobin; H V Vinters; R J Greff
Journal:  Neurosurgery       Date:  1998-11       Impact factor: 4.654

8.  Treatment of dural fistulas involving the deep cerebral venous system.

Authors:  V V Halbach; R T Higashida; G B Hieshima; C B Wilson; C W Hardin; E Kwan
Journal:  AJNR Am J Neuroradiol       Date:  1989 Mar-Apr       Impact factor: 3.825

9.  Transvenous embolization of dural fistulas involving the cavernous sinus.

Authors:  V V Halbach; R T Higashida; G B Hieshima; C W Hardin; H Pribram
Journal:  AJNR Am J Neuroradiol       Date:  1989 Mar-Apr       Impact factor: 3.825

10.  Selection and combination of techniques for treating spontaneous carotid-cavernous sinus fistulas.

Authors:  K Kinugasa; K Tokunaga; I Kamata; S Mandai; K Sugiu; A Handa; T Ohmoto
Journal:  Neurol Med Chir (Tokyo)       Date:  1994-09       Impact factor: 1.742
  10 in total
  16 in total

1.  Transvenous treatment of spontaneous dural carotid-cavernous fistulas using a combination of detachable coils and Onyx.

Authors:  S Suzuki; D W Lee; R Jahan; G R Duckwiler; F Viñuela
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

2.  Transvenous embolization of cavernous sinus dural arteriovenous fistulas using detachable coils and Glubran 2 acrylic glue via the inferior petrosal sinus approach.

Authors:  Zheng-Ran Li; Zai-Bo Jiang; Ming-Sheng Huang; Kang-Shun Zhu; Qing Wang; Hong Shan
Journal:  Eur Radiol       Date:  2010-07-02       Impact factor: 5.315

3.  Carotid-cavernous fistula: current concepts in aetiology, investigation, and management.

Authors:  A D Henderson; N R Miller
Journal:  Eye (Lond)       Date:  2017-11-03       Impact factor: 3.775

4.  Transarterial treatment of direct carotico-cavernous fistulas with coils and Onyx.

Authors:  Arvinda Hanumanthapura Ramalingaiah; Chandrajit Prasad; Paramveer Singh Sabharwal; Jitender Saini; Paritosh Pandey
Journal:  Neuroradiology       Date:  2013-07-05       Impact factor: 2.804

5.  A promising adjuvant to detachable coils for cavernous packing: onyx.

Authors:  X Lv; C Jiang; Y Li; Z Wu
Journal:  Interv Neuroradiol       Date:  2009-09-01       Impact factor: 1.610

6.  Onyx embolization of anterior condylar confluence dural arteriovenous fistula.

Authors:  Koichiro Takemoto; Satoshi Tateshima; Sachin Rastogi; Nestor Gonzalez; Reza Jahan; Gary Duckwiler; Fernando Vinuela
Journal:  BMJ Case Rep       Date:  2013-03-04

7.  Long-term results and patients' satisfaction after transurethral ethylene vinyl alcohol (Tegress) injections: a two-centre study.

Authors:  Annette Kuhn; Werner Stadlmayr; Amara Sohail; Ash Monga
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-10-23

8.  Embolization of cranial dural arteriovenous fistulae with ONYX: Indications, techniques, and outcomes.

Authors:  Rashmi Saraf; Manish Shrivastava; Nishant Kumar; Uday Limaye
Journal:  Indian J Radiol Imaging       Date:  2010-02

9.  Treatment of carotid cavernous fistulas using covered stents: midterm results in seven patients.

Authors:  F Gomez; W Escobar; A M Gomez; J F Gomez; C A Anaya
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

10.  Endovascular treatment of cranial dural arteriovenous fistulae: a single-centre, 14-year experience and the impact of Onyx on local practise.

Authors:  Jason Hector Michael Macdonald; John S Millar; C S Barker
Journal:  Neuroradiology       Date:  2009-11-04       Impact factor: 2.804
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.